Maria J. Ribal
@MariaJRibal
Head of Uro-Oncology Unit. @hospitalclinic. Chair of #eauguidelines Office https://uroweb.org/guidelines In love with Urology!! Passion for life!!!
Strong Andrology girl power publication w amazing @UCLH team … rdcu.be/exM9W Patient satisfaction in priapism patients with penile implants, excellent article to help counsel patients in a difficult setting @isabeldijeroo @aislinglooney @chloemount @fionaholdenuclh
Just came online in @TheLancet 👉Our two papers on improved OS with Enzalutamide + Talazoparib in mCRPC #ProstateCancer in all-comer & HRRm patients (Median OS and HRs👇). Weblinks to the papers👉 bit.ly/4lXkLtB and bit.ly/4nNIyOh @PCFnews @urotoday @OncoAlert
Just in👉Two @TheLancetOncol papers on patient-reported QOL results in ph3 TALAPRO-2 trial👉in all-comer & HRR deficient mCRPC #ProstateCancer pts👉Improved OS without compromising QOL👇Links: bit.ly/3DWHlSR & bit.ly/3E3SSQi @urotoday @OncoAlert @PCFnews 👇
Johnson & Johnson receives U.S. FDA Priority Review for TAR-200 NDA in high-risk non-muscle invasive bladder cancer jnj.com/media-center/p…
Feet on the desk!! ( such a long time now…🧐🧐) it’s that time again ☀️ Time to unplug, reconnect with nature and (hopefully) recharge. Wishing you all a peaceful summer off!! And 🙏🏻🙏🏻🙏🏻. may the second half of the year be gentler, brighter, and full of purpose. #SummerBreak…
Felicitats a la Dra. Maria Reig @ma5RN per liderar una iniciativa clau des del coneixement, la visió i el compromís. Reconeixement, lideratge clínic i mirada estratègica són més necessaris que mai per construir el futur que volem. Orgullosa de compartir camí amb companyes que…
🎓 Nova Càtedra UB BCLC per impulsar el coneixement i la prevenció del #càncer de fetge 🔬 Neix amb l’objectiu de traslladar a la societat els coneixements actuals de la malaltia i presentar els reptes que hi ha per millorar-ne l’atenció, la innovació i la #investigació ➕ Info…
Gisele Pelicot awarded France's Legion of Honour - BBC News Absolutely deserved..! bbc.com/news/articles/…
🆕 Check this out! The 2025 #EAUGuidelines on #Urolithiasis are now published in European Urology 📘 🔍 Covering: ✅ State-of-the-art imaging (US, low-dose CT) ✅ MET, ESWL, URS, PCNL ✅ Genetic testing in high-risk patients ✅ Personalized treatment pathways ✅ Practical…
🎓 Nova Càtedra UB BCLC per impulsar el coneixement i la prevenció del #càncer de fetge 🔬 Neix amb l’objectiu de traslladar a la societat els coneixements actuals de la malaltia i presentar els reptes que hi ha per millorar-ne l’atenció, la innovació i la #investigació ➕ Info…
Breaking News from ph3 Embark trial👉Enzalutamide+ADT improve overall survival (OS) vs. ADT alone in Non-Metastatic HSPC #Prostatecancer Congrats to @SFreedlandMD @nealshore & team! Earlier enza works better! Link👉 rb.gy/iyc3f2 @OncoAlert @urotoday @PCFnews
💫🌟🎯 Long-term surveillance in young adult cancer survivors 📌 Egger-Heidrich et al. | Cancer Treatment Reviews, 2025 💥 “Survival is not enough — thriving requires tailored follow-up.” @Cancers_MDPI @OncoAlert 🔎 Key insights: ✔️YACS face unique risks: SMN, cardiotoxicity,…
🌟Challenges in Defining Clinical CR to Systemic Therapy in MIBC🌟 @EORTC #STARBURST project 🖋️ Alexandra Masson-Lecomte @AFUrology, Guillaume Grisay, @vandamme_jvd, @Achard_Verane , @LAUrology_NL, @robert_huddart, @frasor86, @LDyrskjot, Yves Allory @institut_curie,…
@US_FDA approves durvalumab for perioperative immunotherapy for patients with muscle-invasive bladder cancer In a prespecified analysis, the trial demonstrated a statistically significant improvement in event-free survival and overall survival. @AmericanCancer @RamalingamMD…
10 years ago, under the vision of @NDowJames, we set out to bring #EAUGuidelines to #socialmedia . It started with a small group, driven by the belief that guidelines become truly valuable when they are shared, discussed, and used together. Leading that first Dissemination…
